These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 32438990)

  • 21. Impact of SYNTAX Score on 10-Year Outcomes After Revascularization for Left Main Coronary Artery Disease.
    Yoon YH; Ahn JM; Kang DY; Park H; Cho SC; Lee PH; Lee SW; Park SW; Park DW; Park SJ
    JACC Cardiovasc Interv; 2020 Feb; 13(3):361-371. PubMed ID: 32029254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radial versus femoral artery access for percutaneous coronary artery intervention in patients with acute myocardial infarction and multivessel disease complicated by cardiogenic shock: Subanalysis from the CULPRIT-SHOCK trial.
    Guedeney P; Thiele H; Kerneis M; Barthélémy O; Baumann S; Sandri M; de Waha-Thiele S; Fuernau G; Rouanet S; Piek JJ; Landmesser U; Hauguel-Moreau M; Zeitouni M; Silvain J; Lattuca B; Windecker S; Collet JP; Desch S; Zeymer U; Montalescot G; Akin I;
    Am Heart J; 2020 Jul; 225():60-68. PubMed ID: 32497906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
    Gyöngyösi M; Christ G; Lang I; Kreiner G; Sochor H; Probst P; Neunteufl T; Badr-Eslam R; Winkler S; Nyolczas N; Posa A; Leisch F; Karnik R; Siostrzonek P; Harb S; Heigert M; Zenker G; Benzer W; Bonner G; Kaider A; Glogar D;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):718-27. PubMed ID: 19695539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials.
    Ahn JM; Park DW; Lee CW; Chang M; Cavalcante R; Sotomi Y; Onuma Y; Tenekecioglu E; Han M; Lee PH; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2017 Jul; 10(14):1415-1424. PubMed ID: 28728654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: Design and rationale of CULPRIT-SHOCK trial.
    Thiele H; Desch S; Piek JJ; Stepinska J; Oldroyd K; Serpytis P; Montalescot G; Noc M; Huber K; Fuernau G; de Waha S; Meyer-Saraei R; Schneider S; Windecker S; Savonitto S; Briggs A; Torremante P; Vrints C; Schuler G; Ceglarek U; Thiery J; Zeymer U;
    Am Heart J; 2016 Feb; 172():160-9. PubMed ID: 26856228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
    Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current clinical management of acute myocardial infarction complicated by cardiogenic shock.
    El Nasasra A; Zeymer U
    Expert Rev Cardiovasc Ther; 2021 Jan; 19(1):41-46. PubMed ID: 33289436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of long-term prognostic value of baseline SYNTAX and clinical SYNTAX scores in ST-segment elevation myocardial infarction patients with multivessel disease.
    Onuk T; Güngör B; İpek G; Karataş MB; Çanga Y; Akyüz Ş; Haci R; Karadeniz FÖ; Sungur A; Kaşikçioğlu H; Çam N
    Coron Artery Dis; 2016 Jun; 27(4):311-8. PubMed ID: 26945185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Revascularization Practices and Outcomes in Patients With Multivessel Coronary Artery Disease Who Presented With Acute Myocardial Infarction and Cardiogenic Shock in the US, 2009-2018.
    Khera R; Secemsky EA; Wang Y; Desai NR; Krumholz HM; Maddox TM; Shunk KA; Virani SS; Bhatt DL; Curtis J; Yeh RW
    JAMA Intern Med; 2020 Oct; 180(10):1317-1327. PubMed ID: 32833024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary percutaneous coronary intervention in patients with acute myocardial infarction, resuscitated cardiac arrest, and cardiogenic shock: the role of primary multivessel revascularization.
    Mylotte D; Morice MC; Eltchaninoff H; Garot J; Louvard Y; Lefèvre T; Garot P
    JACC Cardiovasc Interv; 2013 Feb; 6(2):115-25. PubMed ID: 23352816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Culprit or multivessel revascularisation in ST-elevation myocardial infarction with cardiogenic shock.
    Park JS; Cha KS; Lee DS; Shin D; Lee HW; Oh JH; Kim JS; Choi JH; Park YH; Lee HC; Kim JH; Chun KJ; Hong TJ; Jeong MH; Ahn Y; Chae SC; Kim YJ;
    Heart; 2015 Aug; 101(15):1225-32. PubMed ID: 25855797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiographic and Clinical Outcomes After Everolimus-Eluting Stenting for Unprotected Left Main Disease and High Anatomic Coronary Complexity.
    Migliorini A; Valenti R; Parodi G; Vergara R; Buonamici P; Cerisano G; Carrabba N; Antoniucci D
    JACC Cardiovasc Interv; 2016 May; 9(10):1001-7. PubMed ID: 27198680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complete Versus Culprit only Revascularisation in Patients with Cardiogenic Shock Complicating Acute Myocardial Infarction: Incidence and Outcomes from the London Heart Attack Group.
    Rathod KS; Koganti S; Jain AK; Rakhit R; Dalby MC; Lockie T; Kalra S; Malik IS; Knight CJ; Whitbread M; Mathur A; Firoozi S; Bogle R; Redwood S; MacCarthy PA; Sirker A; O'Mahony C; Wragg A; Jones DA
    Cardiovasc Revasc Med; 2020 Mar; 21(3):350-358. PubMed ID: 31327710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.
    Chen SL; Han YL; Zhang YJ; Ye F; Liu HW; Zhang JJ; Xu B; Jiang TM; Zhou YJ; Lv SZ
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1233-41. PubMed ID: 24239199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multivessel versus culprit lesion only percutaneous coronary intervention in cardiogenic shock complicating acute myocardial infarction: A systematic review and meta-analysis.
    de Waha S; Jobs A; Eitel I; Pöss J; Stiermaier T; Meyer-Saraei R; Fuernau G; Zeymer U; Desch S; Thiele H
    Eur Heart J Acute Cardiovasc Care; 2018 Feb; 7(1):28-37. PubMed ID: 28703046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of long-term patient outcome after contemporary left main stenting using the SYNTAX and SYNTAX II scores: A comparative analysis from the FAIL-II multicenter registry (failure in left main study with 2nd generation stents-Cardiogroup III study).
    Cerrato E; Barbero U; Quadri G; Ryan N; D'Ascenzo F; Tomassini F; Quirós A; Bellucca S; Conrotto F; Ugo F; Kawamoto H; Rolfo C; Pavani M; Mejia-Renteria H; Gili S; Iannaccone M; Debenedictis M; Baldassarre D; Biondi-Zoccai G; Colombo A; Varbella F; Escaned J
    Catheter Cardiovasc Interv; 2020 Jul; 96(1):E17-E26. PubMed ID: 31478334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Culprit Lesion Location With Outcomes of Culprit-Lesion-Only vs Immediate Multivessel Percutaneous Coronary Intervention in Cardiogenic Shock: A Post Hoc Analysis of a Randomized Clinical Trial.
    Farhan S; Vogel B; Montalescot G; Barthelemy O; Zeymer U; Desch S; de Waha-Thiele S; Maier LS; Sandri M; Akin I; Fuernau G; Ouarrak T; Hauguel-Moreau M; Schneider S; Thiele H; Huber K
    JAMA Cardiol; 2020 Dec; 5(12):1329-1337. PubMed ID: 32845312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SYNTAX score: an independent predictor of long-term cardiac mortality in patients with acute ST-elevation myocardial infarction.
    Yang CH; Hsieh MJ; Chen CC; Chang SH; Wang CY; Lee CH; Hsieh IC
    Coron Artery Dis; 2012 Nov; 23(7):445-9. PubMed ID: 22968215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes After Coronary Stenting or Bypass Surgery for Men and Women With Unprotected Left Main Disease: The EXCEL Trial.
    Serruys PW; Cavalcante R; Collet C; Kappetein AP; Sabik JF; Banning AP; Taggart DP; Sabaté M; Pomar J; Boonstra PW; Lembo NJ; Onuma Y; Simonton CA; Morice MC; McAndrew T; Dressler O; Stone GW
    JACC Cardiovasc Interv; 2018 Jul; 11(13):1234-1243. PubMed ID: 29976359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Interventions in Patients With Unprotected Left Main Coronary Artery Disease.
    Zheng Z; Xu B; Zhang H; Guan C; Xian Y; Zhao Y; Fan H; Yang Y; Wang W; Gao R; Hu S
    JACC Cardiovasc Interv; 2016 Jun; 9(11):1102-11. PubMed ID: 27282597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.